Fig. 5From: Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteersRepresentative whole-body decay-corrected maximum-intensity-projection images of [11C]CB184. Images were obtained at 1–5, 38–45, and 95–102 min after intravenous injection of [11C]CB184 into a healthy male subjectBack to article page